DROR Dror Ortho-Design, Inc. OTC · United States

Dror Ortho-Design (DROR) news

Dror Ortho-Design, Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker DROR, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Dror Ortho-Design news

We have not published a story on Dror Ortho-Design yet. When there is news, it will appear here.

Dror Ortho-Design annual financials

Line	FY2025	FY2024
Research and development	$815,902	$1.5 million
Net income (loss)	-$2.5 million	-$5.8 million
Cash from operations	-$2.1 million	-$2.7 million
Cash and equivalents	$228,540	$549,444

Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $93,563.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about Dror Ortho-Design

What is the ticker symbol of Dror Ortho-Design?

Dror Ortho-Design, Inc. trades under the ticker DROR on OTC.

Where is Dror Ortho-Design listed?

Dror Ortho-Design, Inc. is listed on OTC.

Which country or territory is Dror Ortho-Design listed under?

Our directory records Dror Ortho-Design, Inc. under United States.

Does aibio.space cover Dror Ortho-Design?

aibio.space lists Dror Ortho-Design, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Is Dror Ortho-Design profitable?

Dror Ortho-Design, Inc. reported a net loss of $2.5 million for the fiscal year ended Dec 31, 2025, and used $2.1 million of cash in operations, per its annual report to the SEC.

How much does Dror Ortho-Design spend on research and development?

$815,902 in the fiscal year ended Dec 31, 2025, per its annual report.

How much cash does Dror Ortho-Design have?

$93,563 in cash at Jun 30, 2026, per its 10-Q.

Investor discussion: Dror Ortho-Design

Members talk about Dror Ortho-Design (DROR). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Dror Ortho-Design, newest first. Each line links the filing it comes from.

Sep 25, 2026Listings
Reported a shareholder vote on a reverse stock split or more authorized shares. SEC Form 8-K (Items 5.07). Source
Sep 9, 2026Listings
Asked shareholders to approve a reverse stock split. SEC Form DEF 14A. Source
Aug 28, 2026Listings
Asked shareholders to approve a reverse stock split. SEC Form PRE 14A. Source

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open OTC:DROR on TradingView.

Listing details

Company: Dror Ortho-Design, Inc.
Ticker: DROR
Listing: OTC
Country or territory: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction